keyboard_arrow_right
Search & Filter keyboard_arrow_right
keyboard_arrow_left Hide
Day 1
keyboard_arrow_leftSearch & Filter
search
Streams
Formats
Day 1
search
Streams
Formats
07:45 - 09:0075 mins
Main Agenda
Registration and Exhibition Open
07:45 - 10:30165 mins
Networking
Continental Breakfast
09:00 - 09:4545 mins
Power - up PartneringONE
Power up partneringONE: Essentials
- Lisa Methley - Senior Director, Online Strategy, EBD Group
09:00 - 10:0060 mins
Morning Workshop 1
How to best articulate the strategic value of your assets to potential investors and partners?
- Ozgur Tuncer - VP Consulting, Strategy Life Science, IQVIA
- Sofia Ioannidou - Partner, Andera Partners
- Ankit Pareek - Senior VP, Jefferies
- Alex Szidon - VP and Head of Business Development, Genentech Research and Early Development, F. Hoffmann-La Roche
- Karen Wagner - Managing Partner, Ysios Capital Partners
09:00 - 10:0060 mins
Morning Workshop 2
Smart drug discovery
- Bert Klebl - Managing Director and CSO, Lead Discovery Center
- Jonas Anielski - Product Life Cycle Manager, Emerging Business Opportunities, Eppendorf
- Sylvie Bove - Senior Advisor, SmiLe Incubator
- Thomas Hanke - Head, Academic Partnerships Europe, Evotec
- Abdelaziz Toumi - Senior Director, Head of Commercial Solutions, Ibex Design & Develop, Lonza
- Jesús Zurdo - Senior VP Innovation and Venture Partnerships, Rentschler Biopharma
10:00 - 18:30510 mins
Partnering
One-to-one Meetings
10:45 - 11:1530 mins
Plenary
Welcome and Opening Remarks
- Pam Putz - Managing Director, EBD Group
- Thilo Rohlfs - State Secretary, Ministry of Economic Affairs, Transport, Employment, Technology and Tourism, Schleswig-Holstein
- Torsten Sevecke - State Secretary, Ministry of Economy, Transport and Innovation of the Free and Hanseatic City of Hamburg
- David Thomas - VP, Industry Research, Biotechnology Innovation Organization (BIO)
11:15 - 11:3015 mins
Plenary
Back to the Future: Milestones from the last 25 years
- Mike Ward - Head of Content Europe, EBD Group and Editor, Europe, Xconomy
11:30 - 12:3060 mins
Plenary
Top of the pops: Greats of the past, leaders of the future
- Kate Bingham - Managing Partner, SV Health Managers
- Werner Lanthaler - CEO, Evotec
- Angeli Moeller - Head IT Business Partnering Research, Bayer
- Jane Osbourn - Chair, BioIndustry Association (BIA) and Mogrify
- Paul Stoffels - Vice Chair of the Executive Committee and CSO, Johnson & Johnson
- Friedrich von Bohlen - CEO, Molecular Health GmbH
12:00 - 14:00120 mins
Networking
Luncheon
13:30 - 14:3060 mins
Business Development Track
Funding trends and how to break them
- Hubert Birner - Managing Partner, TVM Life Science Management Inc.
- Sascha Bucher - Head, Global Transactions, Roivant
- Katie Hewitt - VP, Transactions, Eli Lilly
- Sean Marett - CBO and CCO, BioNTech
- Enno Spillner - CFO, Evotec
13:30 - 14:3060 mins
Spotlight On
Evolving priorities in women’s health
- Lucie Ellis - Executive Editor, In Vivo, Informa Pharma Intelligence
- Ksenija Pavletic Aranicki - CEO, PregLem SA
- Patrick Jordan - CEO, Mycovia Pharmaceuticals
- Mary Kerr - CEO, KaNDy Therapeutics Ltd
- Sabrina Martucci Johnson - President and CEO, Daré Bioscience, Inc.
- Karl Ziegelbauer - Senior VP, Open Innovation and Digital Technologies, Bayer AG
13:30 - 14:3060 mins
Therapeutic Track
Immuno-oncology: Optimizing success in the crowded partnering market, and trends for 2020
- Robert Darwin - Partner, Dechert LLP
- Shawn Bridy - VP, Business Development, Inovio Pharmaceuticals
- Annalisa Jenkins - Chair of the Board of Directors, Cell Medica
- Rainer Kramer - CBO and Managing Director, Immatics
- Brendan Luu - VP, Head, Oncology Business Development, Merck KGaA
- Guillaume Vignon - Senior VP Business Development, BeiGene Switzerland GmbH
13:30 - 17:30240 mins
Presentations
Pharma Presentations
14:45 - 15:4560 mins
Business Development Track
The China market: Valuable opportunities, sophisticated business models, novel science
- Ruediger Herrmann - Partner, McDermott, Will & Emery
- Ming Fang - Global Head Business Development, Elpiscience
- Vivian Feng - Senior Director Business Development, Fosun Pharma
- Ji Li - Venture Partner, Lilly Asia Ventures
- James Huang - Managing Partner, Panacea Venture
- Jonathan Wang - VP & Head of BD, Zai Lab
14:45 - 16:1590 mins
Spotlight On
CNS Company Presentations
14:45 - 15:4560 mins
Therapeutic Track
Immuno-Oncology Company Presentations
15:00 - 16:0060 mins
Power - up PartneringONE
Power up partneringONE: Experienced
- Lisa Methley - Senior Director, Online Strategy, EBD Group
15:00 - 17:00120 mins
Let's talk...series
Let's talk...CARDIOLOGY
- Lucie Carrier - Professor of Functional Genomics of Cardiomyopathies, Institute of Experimental Pharmacology and Toxicology, University Medical Center Hamburg-Eppendorf
- Thomas Eschenhagen - Director, Institute of Experimental Pharmacology and Toxicology, University Medical Centre Hamburg-Eppendorf; Chairman, German Centre for Cardiovascular Research (DZHK)
- Robert Fischer - CEO, OMEICOS
- Berthold Hinzen - VP and Head BD&L,Therapeutic Areas, Bayer AG
- Johannes Holzmeister - Chairman and CEO, DiNAQOR
- Philip Larsen - Senior VP, Global Head, Research, Bayer
- Alexander Meyer - Physician and Computer Scientist, German Center of Cardiovascular Research (DZHK)
- Andreas Scheel - EVP Cell Therapy, Evotec
- Frank Schoening - Senior VP, Global Head, Strategic Marketing Cardiovascular, Bayer
- Frans Wuite - CEO, Acesion Pharma
16:00 - 17:0060 mins
Business Development Track
Emerging pharma first launch and partnering
- Ben Hohn - Principal, BD, Pipeline and Launch Strategy, ZS Associates
- Joe Dupere - CEO, Rexgenero Ltd
- Andrew Hotchkiss - CCO, Immunocore
16:00 - 17:0060 mins
Therapeutic Track
Workable business models for AMR innovation
- Sandra Wirsching - Director Business Development and Managing Editor, BIOCOM AG
- Michel de Baar - Executive Director, Business Development, Europe, MSD
- Yann Ferrisse - Head of Business Development, Global Antibiotic R&D Partnership (GARDP)
- Cyrille Kuhn - Head of Research Beyond Borders US, Boehringer Ingelheim
- Diego Tonelli - Investment Economist, European Investment Bank
- Holger Zimmermann - CEO, AiCuris Anti-infective Cures
16:05 - 16:2520 mins
Extra Activity
Break and Breathe
16:15 - 17:1560 mins
Spotlight On
How to cope: Transversing the neuro path
- Mike Ward - Head of Content Europe, EBD Group and Editor, Europe, Xconomy
- John Isaac - Senior Director, External Scientific Innovation, Neuroscience, Johnson & Johnson Innovation
- Jill Richardson - Senior Director, MSD
- Lesley Stolz - Executive VP and CBO, Annexon Biosciences
- Marie Trad - VP, Therapeutic Area Head, CNS Division, IQVIA Biotech
16:35 - 16:5520 mins
Extra Activity
Break and Breathe
17:15 - 18:0045 mins
Business Development Track
Dealmaking in the microbiome field: The coming of age
- Eric de La Fortelle - Managing Director, Health Opportunities GmbH
- Gil Bar-Nahum - Managing Director, Jefferies
- Rodolphe Clerval - CBO, Enterome
- Jean-Christophe Hyvert - CCO, LPBN, Lonza Pharma and Biotech
- Isabelle de Cremoux - CEO and Managing Partner, Seventure
- Jonathan Solomon - CEO, BiomX
17:15 - 18:1560 mins
Therapeutic Track
Infectious Disease Company Presentations
18:00 - 18:4545 mins
Networking
Champagne reception at EBD Group booth #161
19:00 - 22:00180 mins
Networking
Evening Networking Reception with Buffet-style Dinner
Get the latest news.
As it happens
Sign up to get the latest on the agenda and speakers.
Filter
Streams
Formats
